OBIO - Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc. Logo

OBIO - Orchestra BioMed Holdings Inc.

https://orchestrabiomed.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - Medtronic ( NYSE:MDT ) , Orchestra BioMed Hldgs ( NASDAQ:OBIO )
Benzinga • 1 week, 3 days ago • score: 0.20
Results from long-term follow up of patients treated with atrioventricular interval modulation ( "AVIM" ) therapy show blood pressure-lowering effects are sustained for years after activation, reversible with no observed rebound hypertension upon deactivation of treatment, and reproducible upon ...
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. The company is headquartered in New Hope, Pennsylvania.

52W High
$6.50
52W Low
$2.37
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.61
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-1.81
EV/Revenue (<3 favorable)
44.43
P/S (TTM) (<3 favorable)
50.40
P/B (<3 favorable)
502.97
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
16.21%
Institutions (25–75% balanced)
34.98%
Shares Outstanding
53,955,000
Float
31,878,300
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
2,944,000
Gross Profit (TTM)
2,728,000
EPS (TTM)
-1.83
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-23.12%
ROE (TTM) (>15% strong)
-3.14%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.08
Momentum
Bearish momentum
Value
-0.0465
Previous
-0.0367
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025